Can I get life insurance with kidney disease?

Yes, depending on the stage and severity. Mild chronic kidney disease (CKD Stage 1–2) with stable GFR and controlled blood pressure is often insurable at table ratings. Advanced CKD (Stage 4–5) or kidney failure requiring dialysis significantly limits traditional coverage options, though guaranteed issue products remain available.

Can I get life insurance with liver disease?

Yes, in many cases. The type and severity of liver disease determines insurability. Fatty liver (NAFLD) with normal liver function is often insurable at standard or near-standard rates. Hepatitis-related liver disease, alcoholic liver disease, and cirrhosis are underwritten more strictly based on current liver function test results and degree of fibrosis.

How does a kidney transplant affect life insurance?

A kidney transplant is a complex underwriting situation. Carriers evaluate time since transplant, current kidney function (creatinine, GFR), immunosuppressive medication regimen, and whether there have been any rejection episodes. Many post-transplant applicants can qualify for coverage 2–5 years after a successful transplant with stable function.

What lab values do underwriters look at for kidney disease?

The primary values are GFR (glomerular filtration rate), creatinine, BUN (blood urea nitrogen), urine protein/creatinine ratio, and blood pressure. A GFR above 60 with controlled blood pressure and no significant proteinuria is the most favorable scenario. GFR below 30 results in significantly higher ratings or declines.

Can I get life insurance if I am on dialysis?

Traditional fully-underwritten life insurance is generally not available for applicants currently on dialysis. However, guaranteed issue whole life insurance — which has no medical questions — remains accessible. Coverage limits are typically $5,000–$25,000 but can still provide meaningful final expense coverage for your family.

Kidney or Liver Disease and Life Insurance

Kidney and liver conditions span a wide spectrum of severity, and underwriters evaluate each case individually based on objective lab values and function tests. Mild, well-monitored kidney or liver disease with stable function can qualify for standard or table-rated coverage. Advanced disease — particularly dialysis dependency, cirrhosis with decompensation, or combined kidney-liver failure — typically results in decline at fully underwritten carriers. The specific condition, lab values, stability over time, and underlying cause are the variables that drive everything.

Kidney Disease: What Underwriters Evaluate

Chronic kidney disease (CKD) is one of the most precisely measurable conditions in underwriting because kidney function can be quantified directly through lab values.

eGFR (Estimated Glomerular Filtration Rate) — The primary kidney function metric. eGFR above 60 (CKD Stage 1–2) often qualifies at standard rates. eGFR 45–59 (Stage 3a) results in table ratings. eGFR 30–44 (Stage 3b) is more restrictive. Below 30 (Stage 4–5) typically results in decline at standard carriers.

Creatinine and BUN — Elevated creatinine or BUN signal impaired kidney filtration. Carriers review trends over time — stable or improving values are viewed much more favorably than rising ones even at the same absolute level.

Proteinuria — Significant protein in the urine signals ongoing kidney damage even when eGFR is preserved. Controlled or absent proteinuria at any CKD stage is viewed more favorably.

Underlying Cause — Diabetic nephropathy is viewed less favorably than hypertensive nephropathy or other causes due to its progressive nature. Polycystic kidney disease (PKD) has its own actuarial profile. IgA nephropathy and lupus nephritis are evaluated based on current function and stability.

Dialysis Status — Current dialysis dependency results in decline at all fully underwritten carriers. Guaranteed issue products remain available.

Kidney Transplant — Post-transplant with stable function (good eGFR, no rejection episodes) is evaluated more favorably than advanced untransplanted CKD. Most carriers require 2–5 years post-transplant with stable function.

Kidney Disease: General Underwriting Outlook

CKD Stage / eGFR	Typical Rating	Best Achievable	Notes
Stage 1–2 (eGFR 60+), minimal proteinuria	Standard to Table 2	Standard at most carriers	Often treated similarly to healthy applicants
Stage 3a (eGFR 45–59), stable	Table 2–6	Table 2 at competitive carriers	Stable function and low proteinuria improve outcome
Stage 3b (eGFR 30–44), stable	Table 6–10	Table 6 at select carriers	Limited options; specialist broker recommended
Stage 4–5 or dialysis	Decline at standard carriers	Guaranteed issue only	Guaranteed issue with graded benefit is typically the only path
Post-transplant, stable, 2+ years	Table 4–8	Table 4 at select carriers	Better than advanced untransplanted CKD in many cases

Guidelines current as of 2025–2026. Verify with us before applying.

Liver Disease: What Underwriters Evaluate

Liver Function Tests (LFTs) — ALT, AST, alkaline phosphatase, bilirubin, albumin, and platelet count are all reviewed. Normal or near-normal LFTs signal a functioning liver. Significantly elevated enzymes or low albumin/platelets indicate progressive damage and result in higher ratings or decline.

Fibrosis and Cirrhosis Stage — Fatty liver (NAFLD) with normal LFTs is viewed most favorably — often at standard rates. Mild fibrosis (F1–F2) is rated but insurable. Advanced fibrosis (F3) and compensated cirrhosis (Child-Pugh A) are more restrictive. Decompensated cirrhosis (ascites, variceal bleeding, encephalopathy) is declined at all standard carriers.

Underlying Cause — NAFLD/NASH is common and viewed relatively favorably when LFTs are normal. Hepatitis B or C history is evaluated based on viral load, treatment outcome (SVR for Hep C), and current liver function. Alcoholic liver disease requires documented sobriety — abstinence duration is a critical factor. Autoimmune hepatitis is rated based on current function and steroid requirements.

Alcohol Use History — For alcohol-related liver disease, documented sobriety is essential. Most carriers require 2–5 years of abstinence before offering coverage. Recent or active drinking alongside liver disease typically results in decline.

Liver Transplant — Post-liver transplant with stable function is evaluated case-by-case. Most carriers require a minimum of 2–5 years post-transplant with stable LFTs, no rejection episodes, and manageable immunosuppressant regimen.

Liver Disease: General Underwriting Outlook

Liver Profile	Typical Rating	Best Achievable	Notes
NAFLD / fatty liver, normal LFTs	Standard to Table 2	Standard at most carriers	Very common; generally treated as minimal additional risk
Mild fibrosis (F1–F2), stable LFTs	Table 2–6	Table 2 at competitive carriers	Stable function and underlying cause are key
Advanced fibrosis (F3), compensated	Table 6–10	Table 6 at select carriers	Limited options; specialist broker recommended
Compensated cirrhosis (Child-Pugh A), stable	Decline at most carriers	Very limited; select specialty carriers only	Highly carrier-dependent; informal shopping essential
Decompensated cirrhosis or active liver failure	Decline at all standard carriers	Guaranteed issue only	Ascites, variceal bleeding, or hepatic encephalopathy = decline
Hep C with SVR (post-treatment, no cirrhosis)	Table 2–6	Table 2 at competitive carriers	SVR dramatically improves outlook vs. untreated Hep C
Alcoholic liver disease, 3+ years abstinence, normal LFTs	Table 4–8	Table 4 at select carriers	Abstinence duration and LFT normalization are critical

Guidelines current as of 2025–2026. Verify with us before applying.

Kidney or Liver Condition? Let’s Find Your Options.

Kidney and liver disease underwriting depends heavily on your specific lab values and disease stage. We review your profile against current carrier guidelines and identify your best options before any formal application is submitted.

Call 1-888-972-0024

Browse All High-Risk Conditions

Understanding Your Rating: Life Insurance Risk Classifications | Table Ratings Explained (B–J) | Flat Extra Ratings

Authoritative Resources: Life insurance underwriting practices are regulated by the NAIC. Insurers may check your health history through the MIB Group — you can request your free annual MIB report at mib.com.